###begin article-title 0
Plasma Levels of Transforming Growth Factor-beta1 Reflect Left Ventricular Remodeling in Aortic Stenosis
###end article-title 0
###begin p 1
Conceived and designed the experiments: AVV MAH JFN. Performed the experiments: AVV MC ML CM FGV RMD JFN. Analyzed the data: AVV MC ML CM MAH JFN. Contributed reagents/materials/analysis tools: FGV RMD MAH. Wrote the paper: AVV MAH JFN.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 219 227 <span type="species:ncbi:9606">patients</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
TGF-beta1 is involved in cardiac remodeling through an auto/paracrine mechanism. The contribution of TGF-beta1 from plasmatic source to pressure overload myocardial remodeling has not been analyzed. We investigated, in patients with valvular aortic stenosis (AS), and in mice subjected to transverse aortic arch constriction (TAC), whether plasma TGF-beta1 relates with myocardial remodeling, reflected by LV transcriptional adaptations of genes linked to myocardial hypertrophy and fibrosis, and by heart morphology and function.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 35 43 <span type="species:ncbi:9606">patients</span>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 321 329 <span type="species:ncbi:9606">patients</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 350 358 <span type="species:ncbi:9606">patients</span>
###xml 760 764 <span type="species:ncbi:10090">mice</span>
###xml 775 783 <span type="species:ncbi:9606">patients</span>
The subjects of the study were: 39 patients operated of AS; 27 healthy volunteers; 12 mice subjected to TAC; and 6 mice sham-operated. Myocardial samples were subjected to quantitative PCR. Plasma TGF-beta1 was determined by ELISA. Under pressure overload, TGF-beta1 plasma levels were significantly increased both in AS patients and TAC mice. In AS patients, plasma TGF-beta1 correlated directly with aortic transvalvular gradients and LV mass surrogate variables, both preoperatively and 1 year after surgery. Plasma TGF-beta1 correlated positively with the myocardial expression of genes encoding extracellular matrix (collagens I and III, fibronectin) and sarcomeric (myosin light chain-2, beta-myosin heavy chain) remodelling targets of TGF-beta1, in TAC mice and in AS patients.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 73 79 <span type="species:ncbi:9606">humans</span>
###xml 302 310 <span type="species:ncbi:9606">patients</span>
###xml 347 354 <span type="species:ncbi:9606">patient</span>
A circulating TGF-beta1-mediated mechanism is involved, in both mice and humans, in the excessive deposition of ECM elements and hypertrophic growth of cardiomyocytes under pressure overload. The possible value of plasma TGF-beta1 as a marker reflecting preoperative myocardial remodeling status in AS patients deserves further analysis in larger patient cohorts.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 175 178 175 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Lindroos1">[1]</xref>
###xml 708 711 708 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Hill1">[2]</xref>
Aortic valve stenosis (AS) is one of the most common valvular diseases whose prevalence is likely to rise in the future with the increase in life expectancy of the population [1]. This entity promotes a pure, progressive, LV pressure overload, which is responsible for biomechanical stress, alterations in the humoral cell environment, and activation of numerous signaling pathways, bringing about structural and functional changes in the myocardium. Typically, LV remodeling under pressure overload is characterized by hypertrophic growth of cardiomyocytes, proliferation of cardiac fibroblasts, increased deposition of extracellular matrix (ECM) constituents and loss of myocytes with fibrotic replacement [2]. The major long-term consequences of this remodeling process are increased myocardial stiffness and decreased compliance resulting, initially, in diastolic dysfunction and, over time, in combined diastolic and systolic heart failure.
###end p 9
###begin p 10
###xml 184 187 178 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Bujak1">[3]</xref>
###xml 189 192 183 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Azhar1">[4]</xref>
###xml 338 341 329 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Azhar1">[4]</xref>
###xml 428 431 419 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Zeisberg1">[5]</xref>
###xml 556 559 544 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Petrov1">[6]</xref>
Abundant experimental evidence indicates that Transforming Growth Factor-beta1 (TGF-beta1) is critically involved in major structural changes of the myocardium under pressure overload [3], [4]. TGF-beta1 acts on cardiomyocytes as well as on cardiac fibroblasts inducing hypertrophy of the former, synthesis of ECM materials by the latter [4] and endothelial-to-mesenchymal transition that recruits fibroblasts to the myocardium [5]. In addition, TGF-beta1 is critically involved in phenotypic modulation of fibroblasts into matrix-producing myofibroblasts [6].
###end p 10
###begin p 11
###xml 137 140 134 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Villarreal1">[7]</xref>
###xml 155 158 152 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Fielitz1">[8]</xref>
###xml 160 163 157 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Villar1">[9]</xref>
###xml 443 446 437 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Fielitz1">[8]</xref>
###xml 448 451 442 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Villar1">[9]</xref>
###xml 676 679 664 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Villar1">[9]</xref>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 296 304 <span type="species:ncbi:9606">patients</span>
Few studies have dealt with such a role for TGF-beta1 in human hypertrophied myocardium from pressure-overload related heart pathologies [7], including AS [8], [9]. Other groups and ours have previously reported increased myocardial expression (at the mRNA and/or protein levels) of TGF-beta1 in patients with severe AS, together with upregulation of collagens I and III and fibronectin, as well as the sarcomeric protein myosin light chain-2 [8], [9]. Our results also support a regulatory role for myocardial TGF-beta1 in the transcriptional activity of these remodeling-related genes, mediated by both the SMAD and the TGF-beta activated kinase 1 (TAK1) signaling pathways [9].
###end p 11
###begin p 12
###xml 139 143 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Takahashi1">[10]</xref>
###xml 160 164 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Gray1">[11]</xref>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 258 266 <span type="species:ncbi:9606">patients</span>
The available experimental reports are focused in analyzing the autocrine and/or paracrine effects of TGF-beta1 released by cardiomyocytes [10] and fibroblasts [11]. In the present study, we investigated, in mice subjected to aortic arch constriction and in patients with severe valvular AS, the contribution of TGF-beta1 from circulating source to pressure overload-induced myocardial remodeling, as reflected by LV transcriptional changes of genes linked to myocardial hypertrophy and fibrosis, and by changes in echocardiographic heart morphology and function.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 45 53 <span type="species:ncbi:9606">Patients</span>
Demographics and Clinical Characteristics of Patients
###end title 14
###begin p 15
###xml 48 55 48 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008476-t001">Table 1</xref>
###xml 319 322 <span type="species:ncbi:9606">men</span>
###xml 327 332 <span type="species:ncbi:9606">women</span>
###xml 446 451 <span type="species:ncbi:9606">women</span>
###xml 709 712 <span type="species:ncbi:9606">men</span>
The characteristics of the cohorts are shown in Table 1. There were no significant differences between control and AS groups in mean age and incidence of atrial fibrillation-flutter. Concerning LV hypertrophy related factors, the mean body mass index and the incidence of obesity and diabetes did not differ between AS men and women and their control pairs. A history of systemic hypertension and the use of diuretics were more frequent among AS women than their controls, but the average systolic and diastolic blood pressures were higher in the control group. There were no other significant differences in the pharmacologic treatment with ACE inhibitors, angiotensin-II receptor antagonists, diuretics (in men), calcium antagonists, statins or beta-blockers between the groups.
###end p 15
###begin title 16
###xml 19 27 <span type="species:ncbi:9606">patients</span>
Characteristics of patients.
###end title 16
###begin p 17
###xml 298 301 298 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2.7</sup>
LVEDDI: Left ventricular end-diastolic diameter index to height; IVSTI: Interventricular septum thickness index to height; PWTI: Posterior wall thickness index to height; LVEDr/PWT: Left ventricular end-diastolic radius to posterior wall thickness ratio; LVMI: Left ventricular mass index to height2.7
###end p 17
###begin p 18
p<0.05;
###end p 18
###begin p 19
p<0.01;
###end p 19
###begin p 20
###xml 29 30 29 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
p<0.001 (two tailed unpaired t test versus same gender control patients).
###end p 20
###begin title 21
Echocardiographic Data
###end title 21
###begin p 22
###xml 142 149 142 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008476-t001">Table 1</xref>
###xml 221 223 219 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 238 240 234 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2,</sup>
###xml 240 241 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 516 523 512 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008476-g001">Fig. 1A</xref>
###xml 655 662 651 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008476-g001">Fig. 1B</xref>
###xml 0 3 <span type="species:ncbi:9606">Men</span>
###xml 8 13 <span type="species:ncbi:9606">women</span>
###xml 161 164 <span type="species:ncbi:9606">men</span>
###xml 252 260 <span type="species:ncbi:9606">patients</span>
Men and women with AS exhibited no significant difference in aortic valve gradients, or in mean aortic valve area index to body surface area (Table 1), although men displayed a larger crude aortic valve area (0.66+/-0.03 vs 0.55+/-0.02 cm2,p<0.01). AS patients of both genders, compared to controls, showed significantly greater indexed IVST and PWT, and lower LVEDr/PWT ratio. No significant difference in LVEF was found between groups. The AS cohorts showed a significant increase in LVMI, compared with controls (Fig. 1A). One year after surgery, LVMI is normalized but PWTI reduction, albeit significant, did not reach the values of healthy controls (Fig. 1B).
###end p 22
###begin title 23
Evolution of left ventricucular mass and posterior wall thickness after aortic valve replacement.
###end title 23
###begin p 24
###xml 81 84 81 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2.7</sup>
###xml 93 94 93 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 168 169 168 169 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 310 311 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 325 326 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 332 334 330 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 357 358 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 365 367 363 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 204 212 <span type="species:ncbi:9606">patients</span>
Left ventricular mass (in grams) indexed to the height (in meters) of the patient2.7 (LVMI) (A) and posterior wall thickness (in mm) indexed to the height (in meters) (B) in control volunteers, and in AS patients preoperatively and one year after valvular replacement. Results are expressed as mean+/-SEM. *** p<0.001 and ** p<0.01 vs healthy controls; ### p<0.001 vs preoperative values (one-way ANOVA and Bonferroni's post-hoc test).
###end p 24
###begin title 25
###xml 3 11 <span type="species:ncbi:9606">Patients</span>
AS Patients Show Increased Plasma Levels of TGF-beta1 in Comparison with Healthy Controls
###end title 25
###begin p 26
###xml 12 21 12 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008476-g002">Figure 2A</xref>
###xml 583 590 566 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008476-g002">Fig. 2A</xref>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
###xml 171 179 <span type="species:ncbi:9606">patients</span>
###xml 483 491 <span type="species:ncbi:9606">patients</span>
As shown in Figure 2A, AS patients show significantly higher preoperative plasma levels of TGF-beta1 when compared with healthy individuals (controls: 9.8+/-0.9 ng/ml; AS patients: 24.2+/-2.2 ng/ml). Plasma levels of TGF-beta1 determined in peripheral venous blood did not differ significantly from levels measured in the coronary sinus (19.7+/-3.4 ng/ml). One year after surgery, TGF-beta1 plasma levels experiment a significant reduction when compared with preoperative values (AS patients, 1 year after surgery: 18.4+/-1.3 ng/ml), but do not reach the values of healthy controls (Fig. 2A).
###end p 26
###begin title 27
Pre- and one year postoperative plasma levels of TGF-beta1 and their relationships with echocardiographic parameters.
###end title 27
###begin p 28
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 163 164 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 185 187 180 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 254 255 249 250 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 544 545 536 537 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 550 551 542 543 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 60 68 <span type="species:ncbi:9606">patients</span>
###xml 289 297 <span type="species:ncbi:9606">patients</span>
###xml 585 593 <span type="species:ncbi:9606">patients</span>
A: Plasma TGF-beta1 levels in control volunteers, and in AS patients preoperatively and one year after valvular replacement. Results are expressed as mean+/-SEM. *p<0.05 and ***p<0.001 vs control volunteers (one-way ANOVA followed by Bonferroni's test). B: Regression lines showing, in AS patients, the correlation between plasma TGF-beta1 concentrations and the mean transvalvular gradients preoperatively (*) and, one year after aortic valve replacement (o), with the residual mean transprosthetic gradients. (Pearson's regression analysis). C and D: Regression lines showing, in AS patients, the correlation between plasma TGF-beta1 concentrations and posterior wall indexed to the height (PWTI) preoperatively (C) and one year after aortic valve replacement (D). (Pearson's regression analysis).
###end p 28
###begin title 29
###xml 135 143 <span type="species:ncbi:9606">Patients</span>
Plasma Levels of TGF-beta1 Are Positively Correlated to Mean Gradients and with Hypertrophy-Related Echocardiographic Parameters in AS Patients
###end title 29
###begin p 30
###xml 123 130 120 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008476-g002">Fig. 2B</xref>
###xml 331 338 325 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008476-g002">Fig. 2B</xref>
###xml 150 158 <span type="species:ncbi:9606">patients</span>
A significant and positive correlation between peripheral TGF-beta1 plasma levels and mean aortic transvalvular gradients (Fig. 2B) was evident in AS patients. Four months (data not shown) and one year after surgery, plasma TGF-beta1 levels still maintain the positive correlation with the residual mean transprosthetic gradients (Fig. 2B).
###end p 30
###begin p 31
###xml 71 85 68 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008476-g002">Figs. 2C and D</xref>
###xml 153 161 <span type="species:ncbi:9606">patients</span>
###xml 300 305 <span type="species:ncbi:9606">women</span>
Plasma TGF-beta1 levels, both preoperatively and 1 year after surgery (Figs. 2C and D), display a significant and direct correlation with PWTI in all AS patients. In addition, a relationship between preoperative TGF-beta1and LVMI (r = 0.72, p<0.01) and IVSI (r = 0.67, p<0.01) was evident only in AS women.
###end p 31
###begin title 32
TGF-beta1 Plasma Levels Are Positively Correlated with LV Myocardial Expression Levels of Genes Encoding Effectors of the TGF-beta1 Signalling Pathways, and with TGF-beta1 Target Genes, Encoding Remodelling-Related Proteins
###end title 32
###begin p 33
###xml 153 159 150 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008476-g003">Fig. 3</xref>
###xml 288 294 282 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008476-g004">Fig. 4</xref>
###xml 374 380 365 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008476-g005">Fig. 5</xref>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Preoperative plasma levels of TGF-beta1 in AS patients sustain a significant positive correlation with LV myocardial SMAD-2 and TAK-1 transcript levels (Fig. 3). The myocardial expression of genes regulated by TGF-beta1, such as the ECM elements collagen I, collagen III and fibronectin (Fig. 4) and the sarcomeric proteins myosin light chain-2 and beta-myosin heavy chain (Fig. 5), are also directly correlated with plasma TGF-beta1 concentrations.
###end p 33
###begin title 34
Relationships between circulating TGF-beta1 and myocardial gene expression of its canonical and non-canonical effectors.
###end title 34
###begin p 35
###xml 124 125 121 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 138 139 135 136 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 201 203 198 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 270 271 267 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 147 155 <span type="species:ncbi:9606">patients</span>
Regression lines show the positive correlation between TGF-beta1 plasma levels and LV myocardial mRNA expression of SMAD-2 (A) and TAK-1 (B) in AS patients. The relative mRNA expression was normalized vs the housekeeping gene, ribosomal subunit 18S, and multiplied by 105. (Pearson's regression analysis).
###end p 35
###begin title 36
Relationships between circulating TGF-beta1 and myocardial gene expression of its target genes of ECM remodeling.
###end title 36
###begin p 37
###xml 136 137 133 134 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 164 165 157 158 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 199 200 188 189 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 274 276 263 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 343 344 332 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 220 228 <span type="species:ncbi:9606">patients</span>
Regression lines show the positive correlation between preoperative plasma levels of TGF-beta1 and myocardial mRNA expression levels of A: collagen I (COLIalpha1), B: collagen III (COLIIIalpha1) and C: fibronectin in AS patients. The relative mRNA expression was normalized vs the housekeeping gene, ribosomal subunit 18S, and multiplied by 105. (Pearson's regression analysis).
###end p 37
###begin title 38
Relationships between circulating TGF-beta1 and myocardial gene expression of sarcomeric target genes.
###end title 38
###begin p 39
###xml 173 174 167 168 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 202 203 196 197 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 266 268 260 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 335 336 329 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 212 220 <span type="species:ncbi:9606">patients</span>
Regression lines show the positive significant correlation between preoperative plasma levels of TGF-beta1 and myocardial mRNA expression levels of beta-myosin heavy chain (A) and myosin light chain-2 (B), in AS patients. The relative mRNA expression was normalized vs the housekeeping gene, ribosomal subunit 18S, and multiplied by 105. (Pearson's regression analysis).
###end p 39
###begin p 40
###xml 82 90 <span type="species:ncbi:9606">patients</span>
To ascertain whether the myocardium was the main source of plasma TGF-beta1 in AS patients, the relationship between plasma and myocardial transcript levels of the cytokine was tested. No significant correlation between both parameters was evidenced (r = 0.27; p = 0.1).
###end p 40
###begin title 41
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 93 101 <span type="species:ncbi:9606">Patients</span>
Mice Subjected to Pressure Overload Feature the Same Response to Plasmatic TGF-beta1 than AS Patients
###end title 41
###begin p 42
###xml 12 20 12 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008476-g006">figure 6</xref>
###xml 127 129 122 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
As shown in figure 6, plasma levels of TGF-beta1 are significantly higher in TAC mice than in sham controls (sham: 0.36+/-0.05 vs TAC: 2.44+/-0.43; p<0.05), and maintain a significant and positive correlation with myocardial mRNA levels of collagens I and III, fibronectin, beta-myosin heavy chain, and with alpha-myosin heavy chain, which is the predominant isoform in rodents. A positive correlation between plasma TGF-beta1 and heart weight index at sacrifice (normalized to body mass) was also evidenced (r = 0.56; p<0.05).
###end p 42
###begin title 43
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Circulating TGF-beta1 in pressure overloaded mice and its relationships with mRNA expression of ECM and sarcomeric remodeling proteins.
###end title 43
###begin p 44
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 109 110 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 116 118 111 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 153 159 148 154 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B to F</bold>
###xml 309 310 301 302 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 337 338 325 326 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 369 370 353 354 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 385 386 369 370 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 417 418 397 398 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 489 491 466 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 558 559 535 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
A: Plasma TGF-beta1 levels in sham (n = 6) and pressure overloaded mice (n = 12). Results are means+/-SEM. **p<0.01 vs sham controls (Student's t test). B to F: Regression lines showing, in 1, and 4 wk TAC mice, the correlation between plasma TGF-beta1 concentrations and myocardial mRNA expression levels of B: Collagen I (COLIalpha1), C: Collagen III (COLIIIalpha1), D: Fibronectin, E: alpha-myosin heavy chain and F: beta-myosin heavy chain. The relative mRNA expression was normalized vs the housekeeping gene, ribosomal subunit 18S, and multiplied by 105. (Pearson's regression analysis).
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 647 651 638 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Christakis1">[12]</xref>
###xml 729 733 720 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Monrad1">[13]</xref>
###xml 113 121 <span type="species:ncbi:9606">patients</span>
###xml 201 209 <span type="species:ncbi:9606">patients</span>
###xml 603 611 <span type="species:ncbi:9606">patients</span>
In the present study, we show that preoperative peripheral venous TGF-beta1 plasma levels appear increased in AS patients compared with age-matched healthy individuals. Few days after surgery, some AS patients show a transient increase in TGF-beta1 levels (data not shown), probably in relation with surgical wound healing processes. During postdischarge follow-up, plasma TGF-beta1 recedes significantly, although on the average values do not normalize during the subsequent 12 months. This finding agrees with the well documented notion that reverse LV remodeling after aortic valve replacement in AS patients starts immediately after operation [12], but progresses at a slow pace taking several years to be completed, if ever [13].
###end p 46
###begin p 47
###xml 143 151 <span type="species:ncbi:9606">patients</span>
###xml 721 729 <span type="species:ncbi:9606">patients</span>
###xml 761 766 <span type="species:ncbi:9606">women</span>
A remarkable observation is that, before surgery, plasma levels of TGF-beta1 were proportional to the degree of pressure overload the LV of AS patients had to bear, suggesting a link between the severity of the pathology and the release of TGF-beta1 to the plasma. Furthermore, 4 months (data not shown) and 1 year after aortic valve replacement, TGF-beta1 plasma levels still maintain a significant positive correlation with the residual transprosthetic gradients, so that these two variables still follow a parallel evolution after removing the hemodynamic burden. As to echocardiographic hypertrophy parameters is concerned, we observed that preoperative PWTI kept a close relationship with plasma TGF-beta1 in all AS patients, and with LVMI and IVSTI in AS women. One year after valve replacement, this relationship persists with PWTI for the complete cohort. These results would indicate that there is an association of TGF-beta1 blood concentration with functional and anatomical parameters reflecting the myocardial changes under pressure overload, so that its levels vary in parallel with changes in the above parameters after valvular replacement.
###end p 47
###begin p 48
###xml 204 207 201 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Bujak1">[3]</xref>
###xml 209 212 206 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Azhar1">[4]</xref>
###xml 263 266 260 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Fielitz1">[8]</xref>
###xml 268 271 265 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Villar1">[9]</xref>
###xml 367 371 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Takahashi1">[10]</xref>
###xml 388 392 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Gray1">[11]</xref>
###xml 762 766 750 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Sciarretta1">[14]</xref>
###xml 821 825 809 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Laviades1">[15]</xref>
###xml 827 831 815 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Derhaschnig1">[16]</xref>
###xml 1027 1031 1012 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Matt1">[17]</xref>
###xml 1456 1460 1438 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Matt1">[17]</xref>
###xml 237 242 <span type="species:ncbi:9606">human</span>
###xml 471 476 <span type="species:ncbi:9606">human</span>
###xml 717 725 <span type="species:ncbi:9606">patients</span>
###xml 1082 1087 <span type="species:ncbi:10090">mouse</span>
###xml 1369 1377 <span type="species:ncbi:9606">patients</span>
###xml 1918 1926 <span type="species:ncbi:9606">patients</span>
The key role for myocardial TGF-beta1 in the regulation of cardiomyocyte hypertrophic growth and ECM deposition during remodeling following pressure overload is well documented in the experimental animal [3], [4] and in a few reports in human related pathologies [8], [9]. The available experimental data reinforce the view that TGF-beta1, released by cardiomyocytes [10] and fibroblasts [11], exerts its effects by acting in an autocrine and/or paracrine manner. In the human scenario, circumstantial evidence suggestive for a contribution of TGF-beta1 from a plasmatic source to pressure overload myocardial remodeling was provided by some reports showing that TGF-beta1 plasma levels are increased in hypertensive patients, with or without metabolic syndrome [14] with target organ damage, including heart hypertrophy [15], [16]. However, the absence in these studies of data from myocardial biopsies precludes the establishment of a cause-effect relationship between plasma TGF-beta1 and LV remodeling. Matt and colleagues [17] reported recently that, in an experimental mutant mouse model of Marfan syndrome that recapitulates the cardiovascular involvement of the disease, circulating levels of TGF-beta1 were significantly increased and correlated with the aortic root diameter. They also suggested the potential value of plasma level of this cytokine in Marfan patients, as a marker of disease progression and/or therapeutic response to treatments [17]. Here, the myocardial transcriptional changes, hallmarks of AS, seem to be under the influence of circulating TGF-beta1, as suggested by the direct correlation between preoperative plasma levels of TGF-beta1 and LV expression of genes encoding ECM elements (collagens I and III and fibronectin) as well as sarcomeric elements (beta-myosin heavy chain and myosin light chain-2). Further, these relationships were absent in the myocardium from a cohort of 16 patients operated of cardiac pathologies, with no LV pressure or volume overload (data not shown).
###end p 48
###begin p 49
###xml 80 88 <span type="species:ncbi:9606">patients</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
###xml 695 700 <span type="species:ncbi:9606">human</span>
###xml 701 709 <span type="species:ncbi:9606">patients</span>
###xml 886 894 <span type="species:ncbi:9606">patients</span>
Inferences from the clinical study are limited by the inherent heterogeneity of patients that exhibit many conditions known to have an influence on LV remodeling (systemic hypertension, obesity, diabetes, medical treatments, lack of genetic homology, unknown duration of the pressure overload situation, etc) and could contribute to weaker, albeit significant, linearity of the correlations. To incorporate further evidence, and using a reverse translational approach, we also showed that this blood borne mediated mechanism is operative in mice subjected to TAC, as plasma TGF-beta1 and myocardial gene expression of remodeling elements are linked by a relationship similar to the one found in human patients. Important inferences from these results are that, in LV pressure overload, circulating TGF-beta1 contributes to the progression of myocardial hypertrophy and fibrosis and, in patients with valvular aortic stenosis, mirrors the myocardial transcriptional activity.
###end p 49
###begin p 50
The direct correlation between plasma levels of TGF-beta1 and myocardial expression of genes encoding SMAD-2 and TAK-1 reinforces the hypothesis that LV remodeling is dependent not only on local, but also on circulating TGF-beta1 mediated mechanisms, involving both canonical and non-canonical downstream effectors, and suggests that the intracellular effectors of TGF-beta1 signaling are under the transcriptional influence of circulating TGF-beta1.
###end p 50
###begin p 51
###xml 126 130 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Grainger1">[18]</xref>
###xml 742 746 730 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Querejeta1">[19]</xref>
###xml 748 752 736 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Wasywich1">[20]</xref>
###xml 1284 1288 1263 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Kuruvilla1">[21]</xref>
###xml 1384 1388 1363 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Diehl1">[22]</xref>
###xml 1443 1447 1422 1426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Jian1">[23]</xref>
###xml 226 234 <span type="species:ncbi:9606">patients</span>
###xml 963 967 <span type="species:ncbi:10090">mice</span>
###xml 1399 1407 <span type="species:ncbi:9606">patients</span>
Our experimental approach does not allow ascertaining the full spectrum of plasmatic TGF-beta1 sources, which can be numerous [18]. Indeed, the first candidate to consider is the stressed myocardium. However, in our cohort of patients, the absence of a significant relationship between TGF-beta1 mRNA expression in LV myocardial and its concentration in neither peripheral nor coronary sinus blood (data not shown) precludes a major contribution of myocardial tissue to circulating TGF-beta1 in this pathology. In addition, coronary sinus and peripheral venous blood concentrations of TGF-beta1 were similar, even though the coronary sinus blood has been reported to reflect better the myocardial status of some remodeling-related biomarkers [19], [20]. Should the myocardium be the main source of plasma TGF-beta1, then a positive gradient from its concentration in coronary sinus blood towards peripheral vein blood would have been evident. Furthermore, in TAC mice, myocardial and plasmatic TGF-beta1 did not correlate either (data not shown). Thus, our data suggest that other sources apart from the myocardium may have additionally contributed to an excess plasma TGF-beta1 in response to pressure overload. Putative contributors could be, among others, the stressed endocardium [21], the circulating blood cells activated by shear stress in the restricted aortic orifice region [22] or, in AS patients, the sclerosed aortic valve tissue [23].
###end p 51
###begin p 52
###xml 383 391 <span type="species:ncbi:9606">patients</span>
###xml 710 718 <span type="species:ncbi:9606">patients</span>
###xml 782 789 <span type="species:ncbi:9606">patient</span>
In summary, the present study provides new evidence on the involvement of a circulating TGF-beta1-mediated mechanism in the excessive deposition of ECM elements and hypertrophic growth of cardiomyocytes in response to pressure overload. Given the moderate power of the association between circulating TGF-beta and LV remodeling variables, a single elevated value of this cytokine in patients with aortic stenosis would be of limited help in surgical decision taking. However and according to our results, an escalating time course of the circulating cytokine may reflect progressive myocardial hypertrophy and fibrosis and could be an additional argument for surgery in some asymptomatic or poorly symptomatic patients. Further clinical longitudinal studies are warranted in larger patient populations to confirm the relative merit of circulating TGF-beta as a clinically useful biomarker of LV remodeling.
###end p 52
###begin title 53
Materials and Methods
###end title 53
###begin title 54
Ethics Statement
###end title 54
###begin p 55
###xml 79 84 <span type="species:ncbi:9606">human</span>
###xml 211 219 <span type="species:ncbi:9606">patients</span>
The study followed the Declaration of Helsinki guidelines for investigation on human subjects. The University Hospital Valdecilla Institutional Ethics and Clinical Research Committee approved the study, and all patients gave written informed consent.
###end p 55
###begin p 56
###xml 11 15 <span type="species:ncbi:10090">mice</span>
The use of mice in the study was approved by the University of Cantabria Institutional Laboratory Animal Care and Use Committee and carried out in accordance with the Declaration of Helsinki and the European Communities Council Directive (86/609/EEC).
###end p 56
###begin title 57
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 57
###begin p 58
###xml 573 580 573 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008476-t001">Table 1</xref>
###xml 88 96 <span type="species:ncbi:9606">patients</span>
###xml 143 146 <span type="species:ncbi:9606">men</span>
###xml 154 159 <span type="species:ncbi:9606">women</span>
###xml 162 170 <span type="species:ncbi:9606">Patients</span>
###xml 229 237 <span type="species:ncbi:9606">patients</span>
###xml 432 440 <span type="species:ncbi:9606">patients</span>
The study was performed on myocardial and plasma samples obtained prospectively from 39 patients with severe AS undergoing cardiac surgery (21 men and 18 women). Patients with aortic or mitral regurgitation greater than mild and patients with major coronary stenosis greater than 50% were ineligible for the study. The control group was constituted by 27 healthy volunteers that were recruited for their ages similar to those of AS patients and lack of previous cardiac disease. The clinical and echocardiographic characteristics of both AS and control groups are shown in Table 1.
###end p 58
###begin title 59
Echocardiography
###end title 59
###begin p 60
###xml 116 124 <span type="species:ncbi:9606">patients</span>
A two-dimensionally guided M-mode transthoracic echocardiogram was performed (Philips-Hewlett Packard, IE 33) in AS patients preoperatively, prior to hospital discharge after valve replacement, and four months and one year postoperatively. In the control individuals, a similar study was performed at the time of blood sampling.
###end p 60
###begin p 61
###xml 387 391 387 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Devereux1">[24]</xref>
###xml 436 438 436 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 445 449 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-DeSimone1">[25]</xref>
###xml 470 473 470 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2.7</sup>
###xml 188 195 <span type="species:ncbi:9606">patient</span>
###xml 418 425 <span type="species:ncbi:9606">patient</span>
M-mode tracings were digitally recorded and analyzed. Internal LVEDD and LVESD diameters, IVST, and PWT were recorded. LV dimensions and wall thicknesses were indexed to the height of the patient. Relative LV end diastolic radius was expressed as the ratio between LV cavity end-diastolic radius and PWT. LVEF was calculated using Quinones formula, and LVM according to Devereux formula [24], indexed to height of the patient to the 2.7th power [25] and expressed in g/m2.7.
###end p 61
###begin title 62
Blood Sampling and Determination of TGF-beta1 Plasma Levels
###end title 62
###begin p 63
###xml 304 308 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Grainger1">[18]</xref>
###xml 81 89 <span type="species:ncbi:9606">patients</span>
Samples were collected from peripheral venous blood of healthy volunteers and AS patients. In the latter group, samples were drawn 24 h preoperatively, at operation from the coronary sinus and, in the postoperative period, at the time of the echocardiographic studies. To minimize platelet degranulation [18], blood was drawn from an antecubital vein without tourniquet, using a syringe with a wide-gauge needle and then gently transferred to a collection tube containing EDTA. Within 15 minutes of blood collection, plasma was separated by centrifugation at 1000xg for 30 minutes. Plasma aliquots were stored at -80degreesC until analysis. Total TGF-beta1 plasma levels were determined by ELISA (Biotrak Easy ELISA, GE Healthcare), following the manufacturer's instructions.
###end p 63
###begin title 64
Myocardial Sampling and Quantitative PCR
###end title 64
###begin p 65
During surgery, myocardial tru-cut needle biopsies (4-10 mg) were taken from the lateral LV wall and immediately frozen in liquid nitrogen.
###end p 65
###begin p 66
###xml 473 501 467 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(housekeeping Ct-problem Ct)</sup>
###xml 518 519 512 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Total myocardial RNA was retro-transcribed into cDNA. Quantitative PCR was conducted using specific TaqMan assays (Applied Biosystems). The expression of genes encoding TGF-beta1, collagen I, collagen III, fibronectin, myosin light chain-2 and beta-myosin heavy chain was normalized to the housekeeping gene, ribosomal subunit 18S, measured in parallel in each sample. Duplicate transcript levels were determined in three independent experiments. Results are expressed as 2(housekeeping Ct-problem Ct) multiplied by 105, being Ct the cycle threshold.
###end p 66
###begin title 67
###xml 29 33 <span type="species:ncbi:10090">Mice</span>
Pressure Overload Studies in Mice
###end title 67
###begin p 68
###xml 172 182 166 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
The experiments were performed in adult (16-20 weeks old) C57BL/6 mice, housed in a room kept at 22degreesC with 12:12 h light/dark cycle, and provided with food and water ad libitum.
###end p 68
###begin p 69
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008476-Rockman1">[26]</xref>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 425 429 <span type="species:ncbi:10090">Mice</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 976 984 <span type="species:ncbi:9606">patients</span>
Pressure overload was induced by controlled constriction of the transverse aortic arch (TAC) as described previously [26]. Briefly, mice were anesthetized by intraperitoneal injection of ketamine (10 mg/kg) and xylazine (15 mg/kg). The aorta was constricted at the mid arch level with a 7/0 polypropylene ligature using as calibrator a blunted 27-gauge (0.41 mm OD) needle, reaching approximately a 70% stenosis in diameter. Mice were sham operated (n = 6) or subjected to TAC for 1 or 4 weeks (n = 6 per group). After completing their follow-up, mice were anesthetized with ketamine and xylazine, blood samples were collected from the retroorbitary sinus, and LV samples were immediately frozen in liquid nitrogen for RNA extraction. Plasma levels of TGF-beta1 were determined by ELISA, and myocardial expression of genes encoding TGF-beta1, collagen I, collagen III, fibronectin, alpha-myosin heavy chain and beta-myosin heavy chain by real time PCR, as described below for patients.
###end p 69
###begin title 70
Statistics
###end title 70
###begin p 71
###xml 95 97 93 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t-</italic>
###xml 461 462 459 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
GraphPad Prism 5.01 software package was used. Values are reported as means+/-S.E.M. Student's t-test was used to assess differences between means of continuous variables. Multiple comparisons were performed using the one-way ANOVA followed by Bonferroni's test. Categorical data were compared by Fisher's exact test. Pearson's regression analysis was used to detect correlations between plasma and gene expression levels and/or echocardiographic parameters. A p value<0.05 was considered significant.
###end p 71
###begin p 72
We acknowledge the technical assistance of Milagros Chasco, R.N., Alaska Fernandez, R.N., Rosario Garralda, R.N., Raquel de la Pinta, Nieves Garcia, Ana Sandoval and Amalia Cavaye.
###end p 72
###begin title 73
References
###end title 73
###begin article-title 74
Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample.
###end article-title 74
###begin article-title 75
Cardiac Plasticity.
###end article-title 75
###begin article-title 76
The role of TGF-beta signaling in myocardial infarction and cardiac remodeling.
###end article-title 76
###begin article-title 77
Cytokine Transforming growth factor beta in cardiovascular development and function.
###end article-title 77
###begin article-title 78
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis.
###end article-title 78
###begin article-title 79
Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts.
###end article-title 79
###begin article-title 80
Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen.
###end article-title 80
###begin article-title 81
###xml 99 104 <span type="species:ncbi:9606">human</span>
Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease.
###end article-title 81
###begin article-title 82
###xml 72 77 <span type="species:ncbi:9606">human</span>
Gender differences of echocardiographic and gene expression patterns in human pressure overload left ventricular hypertrophy.
###end article-title 82
###begin article-title 83
###xml 76 79 <span type="species:ncbi:10116">rat</span>
Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes.
###end article-title 83
###begin article-title 84
Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts.
###end article-title 84
###begin article-title 85
Left ventricular mass regression early after aortic valve replacement.
###end article-title 85
###begin article-title 86
Time course of regression of left ventricular hypertrophy after aortic valve replacement.
###end article-title 86
###begin article-title 87
###xml 90 98 <span type="species:ncbi:9606">patients</span>
Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome.
###end article-title 87
###begin article-title 88
Transforming growth factor beta in hypertensives with cardiorenal damage.
###end article-title 88
###begin article-title 89
Increased levels of transforming growth factor-beta1 in essential hypertension.
###end article-title 89
###begin article-title 90
Circulating transforming growth factor-beta in Marfan syndrome.
###end article-title 90
###begin article-title 91
TGF-beta in blood: a complex problem.
###end article-title 91
###begin article-title 92
###xml 39 47 <span type="species:ncbi:9606">patients</span>
Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis.
###end article-title 92
###begin article-title 93
###xml 109 117 <span type="species:ncbi:9606">patients</span>
###xml 146 154 <span type="species:ncbi:9606">patients</span>
Coronary sinus and ascending aortic levels of aldosterone, angiotensin II, and B-type natriuretic peptide in patients with aortic stenosis and in patients with coronary heart disease.
###end article-title 93
###begin article-title 94
Endocardial endothelial cells stimulate proliferation and collagen synthesis of cardiac fibroblasts.
###end article-title 94
###begin article-title 95
###xml 50 58 <span type="species:ncbi:9606">patients</span>
Increased levels of circulating microparticles in patients with severe aortic valve stenosis.
###end article-title 95
###begin article-title 96
Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis.
###end article-title 96
###begin article-title 97
###xml 60 63 <span type="species:ncbi:9606">man</span>
Echocardiographic determination of left ventricular mass in man.
###end article-title 97
###begin article-title 98
Gender differences in left ventricular growth.
###end article-title 98
###begin article-title 99
###xml 112 118 <span type="species:ncbi:10090">murine</span>
Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy.
###end article-title 99
###begin p 100
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 100
###begin p 101
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by grants from the Instituto de Salud Carlos III (PI 060240) to JFN, and Ministerio de Ciencia e Innovacion (SAF2007-65451) to MAH. Dr. Nistal is in the Scientist Stabilization and Research Activity Intensification Program of the National Health System, funded by the Instituto de Salud Carlos III and Comunidad Autonoma de Cantabria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 101

